Hydrogel-Based Biomaterials in Spinal Repair: Evaluating Mechanisms for IVDD, SCI, and Dural Regeneration.

This comprehensive review examines how hydrogel-based materials might revolutionize treatment for spinal conditions, particularly intervertebral disc degeneration (IVDD) and spinal cord injury (SCI). IVDD causes chronic low back pain affecting approximately 266 million people worldwide annually, while SCI can result in permanent neurological damage. Current treatments including pain management, surgery, and cell therapies have limited effectiveness.

Researchers analyzed recent developments in hydrogel biomaterials for spinal repair. Hydrogels are water-rich, gel-like substances that can mimic the body's natural tissue structure. Their key advantages include biocompatibility, adjustable mechanical properties, and the ability to deliver drugs and cells directly to damaged areas. Because they can be injected, they enable minimally invasive procedures rather than major surgery.

The review found that hydrogels show promise for regenerating damaged spinal discs, reducing inflammation, supporting nerve regrowth, and preventing scar tissue formation. However, challenges remain including achieving adequate mechanical strength, controlling how therapeutic agents are released over time, and producing consistent results with 3D printing techniques.

For patients with chronic back pain or spinal injuries, this research is important because it represents a potential alternative to traditional treatments. While hydrogel therapies are still being developed and optimized for clinical use, they may eventually offer less invasive options with better outcomes. Patients currently managing spinal conditions through integrative approaches including acupuncture may benefit from understanding these emerging treatment possibilities. If considering acupuncture for back pain or related conditions, seek care from a licensed acupuncturist certified by national or state regulatory boards.

This review synthesizes current evidence on hydrogel biomaterials for spinal disorder treatment, focusing on intervertebral disc degeneration (IVDD) and spinal cord injury (SCI). IVDD affects approximately 266 million individuals annually and involves ECM degradation, nucleus pulposus dehydration, and inflammation. SCI results in irreversible neurological impairment through primary mechanical trauma and secondary inflammatory cascades including glial scarring and axonal disruption.

The authors conducted a comprehensive analysis of hydrogel applications in spinal repair, examining biological mechanisms, material design, and fabrication techniques. Key advantages identified include biocompatibility, tunable mechanical properties, ECM mimicry, high water content enabling drug/cell delivery, and injectable properties for minimally invasive procedures. Hydrogels demonstrate potential for nucleus pulposus regeneration, inflammation modulation, axonal regrowth support, and fibrosis prevention.

Limitations include insufficient mechanical strength, suboptimal controlled therapeutic delivery, and inconsistent 3D printing outcomes. Clinical application requires optimization of material properties. This comprehensive review provides foundational knowledge for practitioners considering integrative approaches to spinal disorder management alongside emerging biomaterial therapies.